State Stem Cell Agency ICOC Governance Subcommittee Agenda 10/13/08

Oct 13, 2008
Main Location: 

California Institute for Regenerative Medicine
210 King Street, 3rd Floor
San Francisco, CA 94107

Additional Locations: 
Sherry Lansing Foundation 2121 Avenue of the Stars Los Angeles, CA 90067
2476 Lancelot Lane Los Angeles, CA 90077
CONNECT 8950 Villa La Jolla Drive Suite A124 La Jolla, CA 92037
Reeve-Irvine Research Center 1105 Gillespie Neuroscience Research Facility (GNRF) 837 Health Science Road University of California at Irvine School of Medicine Irvine, CA 92697-4292
Klein Financial Corporation 550 California Ave., Suite 330 Palo Alto, CA 94306
UC Davis School of Medicine 4610 X Street, Suite 3103 Sacramento, CA 95817

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

California State Stem Cell Agency

 

Regular Meeting of the ICOC to the CIRM

GOVERNANCE SUBCOMMITTEE
OF THE INDEPENDENT CITIZENS OVERSIGHT COMMITTEE ("ICOC")
TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE (CIRM)

Organized Pursuant To Government Code section 11346.5(a)(17)
and
The CALIFORNIA STEM CELL RESEARCH AND CURES ACT

 
Date: October 13, 2008

Time:  3:30 PM- 5:30 PM (Estimated)

Locations:

 
  • California Institute for Regenerative Medicine
    210 King Street, 3rd Floor
    San Francisco, CA 94107
     
  • Sherry Lansing Foundation
    2121 Avenue of the Stars
    Los Angeles, CA 90067 

 

  • 2476 Lancelot Lane
    Los Angeles, CA 90077
  • CONNECT
    8950 Villa La Jolla Drive
    Suite A124
    La Jolla, CA 92037
  • Reeve-Irvine Research Center
    1105 Gillespie Neuroscience Research Facility (GNRF)
    837 Health Science Road
    University of California at Irvine School of Medicine
    Irvine, CA 92697-4292
  • Klein Financial Corporation
    550 California Ave., Suite 330
    Palo Alto, CA 94306
  • UC Davis School of Medicine
    4610 X Street, Suite 3103
    Sacramento, CA 95817

 

OPEN SESSION

  1. Call to Order.
  2. Roll Call.

    [Members of the Public will be invited to provide testimony before or during consideration of each agenda item. Speakers are asked to limit their testimony to three (3) minutes.]

  3. Consideration of key ICOC meeting policies, including but not limited to, modification of the ICOC bylaws to permit limited participation in board meetings by telephone or teleconference issues to discuss and finalize for recommendation to the ICOC in December 2008.
  4. Update report on contracts and interagency agreements.
 

CLOSED SESSION

  1. Discussion of Personnel (Government Code section 11126, subdivision (a); Health & Safety Code section 125290.30(d) (3) (D)).
 

OPEN SESSION

  1. Public comment.
  2. Adjournment.

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.
Notice is hereby given that the order of consideration of matters on this agenda may be changed without prior notice.

 


 

**NOTICE**

 

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at 415-396-9100 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Melissa King at the California Institute for Regenerative Medicine at mking@cirm.ca.gov or 415-396-9100.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at http://www.cirm.ca.gov.

 

Transcripts: 

© 2013 California Institute for Regenerative Medicine